Venetoclax–Rituximab ± Bendamustine vs Bendamustine–Rituximab in Follicular Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Venetoclax-Rituximab ± Bendamustine vs Bendamustine-Rituximab in Relapsed/Refractory Follicular Lymphoma: CONTRALTO
Blood 2020 Aug 12;[EPub Ahead of Print], PL Zinzani, IW Flinn, SLS Yuen, MS Topp, C Rusconi, I Fleury, K Le Dû, C Arthur, B Pro, G Gritti, M Crump, A Petrich, D Samineni, A Sinha, E Punnoose, E Szafer-Glusman, N Spielewoy, M Mobasher, K Humphrey, M Kornacker, W HiddemannFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.